What can the food industry teach pharma about the benefits of digital supply chain compliance monitoring and management?

Given the criticality of end-to-end quality assurance to pharma compliance, marketing authorisation and patient safety, it is puzzling that entire industry supply chains are not subjected to more rigorous, systemised scrutiny. Even today, the vast majority of drug manufacturers perform global supplier vetting, logging, updating and reporting manually. This outdated approach is fraught with risk, while its labour intensity can result in annual costs approaching 100,000 euros for smaller companies and over half a million for larger entities, to monitor and manage all suppliers.

Don’t have an account yet? Subscribe now, it’s free!

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.

All pubblications

archive from 2022 to today

All articles

PDF Version

Receive our latest issue alerts

directly to your mailbox

And many other benefits!

Register